INTERNAL RADIOTHERAPY OF LIVER CANCER_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

Department of Hepato-Bilio-Pancreatic Surgery, First Affiliated Hospital,West China University of Medical Science, Chengdu 610041;

Corresponding author：

Keywords：

Liver cancer Internal radiotherapy

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To study the development of internal radiotherapy for liver cancer and the relationship between effects and radiation doses.
Methods Literature about internal radiotherapy of liver cancer were collected and reviewed.
Results The rational selection of radioactive microsphere,the appropriate control of radiation dosage and the path of internal radiotherapy are crucial in improving the therapy effects and decreasing the complications. Conclusion The two-stage operation of liver cancer which is on the base of combining chemotherapy, radiotherapy and immunotherapy is the way to go of liver cancer therapy.

Citation： LI Zhihui,YAN Lnan.. INTERNAL RADIOTHERAPY OF LIVER CANCER. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2001, 8(4): 273-275. doi: Copy

1.	Grady ED. Intrahepaticaterial 90 Yttriumresin spheres to treat liver cancer 〔Ｊ〕.J Nucle Med Bio,1978; 5(6)∶235.
2.	Mantravadi RVP, Spigos DG, Tan WS, et al. Intraarterial Yttrium 90 in the treatment of hepatic magilinancy 〔Ｊ〕. Radiology,1982; 142(3)∶783.
3.	Nakakuma K, Tashiro S, Hiraoka T, et al. Studies on the anticancer treatment with oily anticancer drug injected into the ligated hepatic artery for liver cancer 〔Ｊ〕,Nichidoku Iho,1979; 24(4)∶675.
4.	Shimabukuro K. Possibility of radiotherapy of hepatic cancer by transcatheter arterial emboliztion with radioactive lipiodol 〔Ｊ〕,Nippon Acta Radiol,1984; 44(1)∶96.
5.	Prinzmetal M,Ornitz EM,Simkin B, et al. Arteriovenous anastomoses in liver,spleen and lungs 〔Ｊ〕. Am J Physiol,1948; 152(1)∶48.
6.	Sylvain H, TsuiChun K, Francis A,et al.Hepatocellular carcinoma:pilot trial of treatment with Y90 microspheres 〔Ｊ〕.Radiology,1989; 172(3)∶857.
7.	严律南，李立，陈晓理等. 32磷玻璃微球肝动脉栓塞治疗晚期肝癌的初步应用〔Ｊ〕. 中华外科杂志， 1996； 34（9）∶526.
8.	周淑珍，刘国廉，祝宵霞等. 放射性钇90玻璃微球制剂局部注射对裸鼠移植性肝癌的疗效观察〔Ｊ〕. 中华放射医学与防护杂志， 1994； 14（2）∶114.
9.	Tian JH, Xu BX, Zhang JM, et al. Ultrasoundguided internal radiotherapy using yttrium90glass microspheres for liver malignancies 〔Ｊ〕. J Nucl Med, 1996; 3(6)∶958.
10.	Okazaki M, Ymasakisono H. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy 〔Ｊ〕. Hepatogastroenterology, 1993; 40(4)∶320.
11.	Narihide G, Toshihisa N, Mitsuo E, et al. Nourishment of hepatocellular carcinoma cells through the portal blood flow with and without transcathete arterial embolization 〔Ｊ〕. Cancer, 1995; 76(5)∶738.
12.	刘鹏程. 经门静脉注入碘油化疗的治疗肝癌的实验研究〔Ｊ〕. 同济医科大学学报， 1994； 23（4）∶312.
13.	Zeng ZC, Tang ZY, Liu KD, et al. Human anti(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131Ilabeled Hepama1 mAb. Preliminary results and disussion 〔Ｊ〕. Cancer Immunol Immunother, 1984; 39(5)∶332.
14.	施乐华，吴孟超，陈汉等. 肝癌注射治疗剂量131碘抗肝癌McAb的RII 〔Ｊ〕. 中华核医学杂志， 1994 ；14（1）∶32.
15.	姜维关，于连英，周淑珍等. 钇90玻璃微球制剂局部注射对裸鼠移植性人肝癌的疗效观察〔Ｊ〕. 中国肿瘤临床， 1994； 1（11）∶861.
16.	Andrews JC, Walker SC, Ackermann RJ, et al. Hepatic radioembolization with yittrium90 containing glass microspheres preliminary results and clinical followup 〔Ｊ〕. J Nucl Med, 1994; 35(10)∶1637.
17.	Lau WY, Leung WT, Ho S, et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yittium90 microspheres： phrase I and Ⅱ study 〔Ｊ〕. Br J Cancer, 1994; 70(5)∶994.
18.	Raoul L, Guyader D, Bretagne F, et al. Prospective randomized trial of chemoembolization versus intraarterial injection of 131IIabeledIodized oil in the treatment of hepatocellular carcinoma 〔Ｊ〕. J Hepatology, 1997; 26(5)∶1156.
19.	Zeng ZC, Tang ZY, Xie H, et al . Radioimmunotherapy for unresectable hepatocellular carcinomausing 131Ihepama1 Mab: preliminary result 〔Ｊ〕. J Cancer Res Clin Oncol, 1993; 119(5)∶257.
20.	李立，严律南，吴宏斌等. 肝动脉栓塞术后肝脏能量代谢变化的探讨〔Ｊ〕. 中华放射学杂志， 1997； 31（5）∶315.
21.	Ho S, Lau WY, Leung TW, et al. Clinical evaluation of the partition model for estimating radiation doses from yttrium90 microspheres in the treatment of hepatic cancer 〔Ｊ〕. Eur J Nucl Med, 1997; 24(3)∶293.
22.	吴建新. 原发性肝癌动脉化疗栓塞后5种并发症的诊治〔Ｊ〕. 江苏医药， 1993； 19（8）∶442.

1. Grady ED. Intrahepaticaterial 90 Yttriumresin spheres to treat liver cancer 〔Ｊ〕.J Nucle Med Bio,1978; 5(6)∶235.
2. Mantravadi RVP, Spigos DG, Tan WS, et al. Intraarterial Yttrium 90 in the treatment of hepatic magilinancy 〔Ｊ〕. Radiology,1982; 142(3)∶783.
3. Nakakuma K, Tashiro S, Hiraoka T, et al. Studies on the anticancer treatment with oily anticancer drug injected into the ligated hepatic artery for liver cancer 〔Ｊ〕,Nichidoku Iho,1979; 24(4)∶675.
4. Shimabukuro K. Possibility of radiotherapy of hepatic cancer by transcatheter arterial emboliztion with radioactive lipiodol 〔Ｊ〕,Nippon Acta Radiol,1984; 44(1)∶96.
5. Prinzmetal M,Ornitz EM,Simkin B, et al. Arteriovenous anastomoses in liver,spleen and lungs 〔Ｊ〕. Am J Physiol,1948; 152(1)∶48.
6. Sylvain H, TsuiChun K, Francis A,et al.Hepatocellular carcinoma:pilot trial of treatment with Y90 microspheres 〔Ｊ〕.Radiology,1989; 172(3)∶857.
7. 严律南，李立，陈晓理等. 32磷玻璃微球肝动脉栓塞治疗晚期肝癌的初步应用〔Ｊ〕. 中华外科杂志， 1996； 34（9）∶526.
8. 周淑珍，刘国廉，祝宵霞等. 放射性钇90玻璃微球制剂局部注射对裸鼠移植性肝癌的疗效观察〔Ｊ〕. 中华放射医学与防护杂志， 1994； 14（2）∶114.
9. Tian JH, Xu BX, Zhang JM, et al. Ultrasoundguided internal radiotherapy using yttrium90glass microspheres for liver malignancies 〔Ｊ〕. J Nucl Med, 1996; 3(6)∶958.
10. Okazaki M, Ymasakisono H. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy 〔Ｊ〕. Hepatogastroenterology, 1993; 40(4)∶320.
11. Narihide G, Toshihisa N, Mitsuo E, et al. Nourishment of hepatocellular carcinoma cells through the portal blood flow with and without transcathete arterial embolization 〔Ｊ〕. Cancer, 1995; 76(5)∶738.
12. 刘鹏程. 经门静脉注入碘油化疗的治疗肝癌的实验研究〔Ｊ〕. 同济医科大学学报， 1994； 23（4）∶312.
13. Zeng ZC, Tang ZY, Liu KD, et al. Human anti(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131Ilabeled Hepama1 mAb. Preliminary results and disussion 〔Ｊ〕. Cancer Immunol Immunother, 1984; 39(5)∶332.
14. 施乐华，吴孟超，陈汉等. 肝癌注射治疗剂量131碘抗肝癌McAb的RII 〔Ｊ〕. 中华核医学杂志， 1994 ；14（1）∶32.
15. 姜维关，于连英，周淑珍等. 钇90玻璃微球制剂局部注射对裸鼠移植性人肝癌的疗效观察〔Ｊ〕. 中国肿瘤临床， 1994； 1（11）∶861.
16. Andrews JC, Walker SC, Ackermann RJ, et al. Hepatic radioembolization with yittrium90 containing glass microspheres preliminary results and clinical followup 〔Ｊ〕. J Nucl Med, 1994; 35(10)∶1637.
17. Lau WY, Leung WT, Ho S, et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yittium90 microspheres： phrase I and Ⅱ study 〔Ｊ〕. Br J Cancer, 1994; 70(5)∶994.
18. Raoul L, Guyader D, Bretagne F, et al. Prospective randomized trial of chemoembolization versus intraarterial injection of 131IIabeledIodized oil in the treatment of hepatocellular carcinoma 〔Ｊ〕. J Hepatology, 1997; 26(5)∶1156.
19. Zeng ZC, Tang ZY, Xie H, et al . Radioimmunotherapy for unresectable hepatocellular carcinomausing 131Ihepama1 Mab: preliminary result 〔Ｊ〕. J Cancer Res Clin Oncol, 1993; 119(5)∶257.
20. 李立，严律南，吴宏斌等. 肝动脉栓塞术后肝脏能量代谢变化的探讨〔Ｊ〕. 中华放射学杂志， 1997； 31（5）∶315.
21. Ho S, Lau WY, Leung TW, et al. Clinical evaluation of the partition model for estimating radiation doses from yttrium90 microspheres in the treatment of hepatic cancer 〔Ｊ〕. Eur J Nucl Med, 1997; 24(3)∶293.
22. 吴建新. 原发性肝癌动脉化疗栓塞后5种并发症的诊治〔Ｊ〕. 江苏医药， 1993； 19（8）∶442.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

INTERNAL RADIOTHERAPY OF LIVER CANCER

Abstract Full text Figures/Tables Video References Cited by

Format

Content